Combination of radiation therapy-immunotherapy for head and neck cancers: Promises kept?

被引：2
作者：
Huguet, F. [1 ]
Durand, B. [1 ]
Atallah, S. [2 ]
Prebet, C. [3 ]
Richard, S. [3 ]
Baujat, B. [2 ]
机构：
[1] Hop Tenon, Serv Oncol Radiotherapie, 4 Rue Chine, F-75020 Paris, France
[2] Serv Oto Rhino Laryngol Chirurg Cerv Faciale, Paris, France
[3] Sorbonne Univ, Serv Oncol Med, Hop Tenon, AP HP, Paris, France
来源：
CANCER RADIOTHERAPIE | 2021年 / 25卷 / 08期
关键词：
Head and neck cancer; Squamous cell carcinoma; Radiotherapy; Chemoradiotherapy; Cisplatin; Immunotherapy; Immune checkpoint inhibitors; PDL1; PD1; Abscopal effect; SQUAMOUS-CELL CARCINOMA; RADIOTHERAPY; CHEMOTHERAPY; NIVOLUMAB; CETUXIMAB; CHEMORADIOTHERAPY; RECURRENT; IMMUNITY; SAFETY; PHASE;
D O I：
10.1016/j.canrad.2021.08.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chemoradiotherapy with concurrent cisplatin has been the standard treatment for locally advanced headand neck squamous cell carcinoma (HNSCC) for over 20 years. Recently, immunotherapy, a new therapeutic class, has emerged for patients with recurrent or metastatic HNSCC and has significantly extendedtheir survival. Will it bring the same benefit to patients with localized tumors? There is a strong rationale for combining radiation therapy and checkpoint inhibitors for HNSCC. Indeed, radiation therapy canhave both immunostimulatory and immunomodulatory effects. This is what explains the famous abscopal effect. The aim of this review is to present the data available on the combination of radiation therapyand immunotherapy for HNSCC. (c) 2021 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. Allrights reserved.
引用
收藏
页码：811 / 815
页数：5
相关论文
共 50 条
  • [31] Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancers
    Le Guevelou, J.
    Bastit, V
    Marcy, P. Y.
    Lasne-Cardon, A.
    Guzene, L.
    Gerard, M.
    Larnaudie, A.
    Coutte, A.
    Beddok, A.
    Calugaru, V
    Johnson, A.
    Gery, B.
    Liem, X.
    Pointreau, Y.
    Bourhis, J.
    Thariat, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 151 : 256 - 265
  • [32] Checkpoint immunotherapy in head and neck cancers
    Zolkind, Paul
    Uppaluri, Ravindra
    CANCER AND METASTASIS REVIEWS, 2017, 36 (03) : 475 - 489
  • [33] The biology of combination immunotherapy in recurrent metastatic head and neck cancer
    Yuan, Xun
    Yi, Ming
    Zhang, Wei
    Xu, Linping
    Chu, Qian
    Luo, Suxia
    Wu, Kongming
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2021, 136
  • [34] Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians
    Outh-Gauer, Sophie
    Alt, Marie
    Le Tourneau, Christophe
    Augustin, Jeremy
    Broudin, Chloe
    Gasne, Cassandre
    Denize, Thomas
    Mirghani, Haitham
    Fabre, Elizabeth
    Menard, Madeleine
    Scotte, Florian
    Tartour, Eric
    Badoual, Cecile
    CANCER TREATMENT REVIEWS, 2018, 65 : 54 - 64
  • [35] The Evolving Paradigm of Immunotherapy in Head-and-neck Squamous Cell Cancers
    Gili, Riccardo
    Bossi, Paolo
    JOURNAL OF HEAD & NECK PHYSICIANS AND SURGEONS, 2024, 12 (01): : 13 - 17
  • [36] Neoadjuvant Immunotherapy in Head and Neck Cancers: A Paradigm Shift in Treatment Approach
    Zotta, Alessia
    Marciano, Maria Luisa
    Sabbatino, Francesco
    Ottaiano, Alessandro
    Cascella, Marco
    Pontone, Monica
    Montano, Massimo
    Calogero, Ester
    Longo, Francesco
    Fasano, Morena
    Troiani, Teresa
    Ciardiello, Fortunato
    Rampetta, Fabiana Raffaella
    Salzano, Giovanni
    Orabona, Giovanni Dell'Aversana
    Califano, Luigi
    Ionna, Franco
    Perri, Francesco
    BIOMEDICINES, 2024, 12 (10)
  • [37] Mechanisms of Resistance and Therapeutic Perspectives in Immunotherapy for Advanced Head and Neck Cancers
    Meci, Andrew
    Goyal, Neerav
    Slonimsky, Guy
    CANCERS, 2024, 16 (04)
  • [38] Two cases of combination therapy with cetuximab, paclitaxel, and cisplatin for advanced head and neck cancer
    Hoch, Matthew A.
    Cousins, Kati
    Nartey, Ruth
    Riley, Keith
    Hartranft, Megan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (07) : 553 - 554
  • [39] Stereotactic body radiation therapy for recurrent head & neck cancers: rethinking nonoperative salvage strategies
    Heron, Dwight E.
    FUTURE ONCOLOGY, 2009, 5 (09) : 1321 - 1325
  • [40] Toxicity syndrome and early competing deaths in head-and-neck cancer undergoing radiation therapy: Observation and hypothesis
    Muzumder, Sandeep
    Srikantia, Nirmala
    MEDICAL HYPOTHESES, 2020, 143
12345